# Electroacupuncture Pretreatment Ameliorates Perioperative Neurocognitive Disorder in Aged Mice by Inhibiting Ferroptosis Through the SIRT1/NRF2/GPX4 Pathway

**Authors:** Zhongying Du, Binsen Zhang, Tianren Chen, Chang Lei, Lu Tang, Sasa Yang, Chunai Wang

PMC · DOI: 10.1111/jcmm.71021 · Journal of Cellular and Molecular Medicine · 2026-01-13

## TL;DR

Electroacupuncture at specific points may help reduce brain-related issues in elderly mice after surgery by preventing a type of cell death called ferroptosis.

## Contribution

This study shows electroacupuncture can ameliorate PND by inhibiting ferroptosis via the SIRT1/NRF2/GPX4 pathway in aged mice.

## Key findings

- EA treatment improved ferroptosis and memory function in hippocampal neurons.
- The SIRT1 inhibitor EX527 prevented EA's beneficial effects, confirming the pathway's role.
- Ferroptosis is closely linked to the development of PND in aged mice.

## Abstract

Perioperative neurocognitive disorder (PND) is a common complication after anesthesia surgery in elderly patients, which not only reduces the patients' quality of life but also increases the burden on their families and society. PND has been found to be closely related to ferroptosis. This study investigated whether electroacupuncture (EA) can inhibit ferroptosis through the SIRT1/NRF2/GPX4 pathway to improve PND in aged mice. The PND model was established using sevoflurane anesthesia and tibial fracture surgery. EA was administered at the Baihui (GV 20) and Dazhui (GV 14) acupoints. Additionally, intraperitoneal injection of silent information regulator sirtuin 1 (SIRT1) inhibitor EX527 (5 mg/kg) was administered for five consecutive days before surgery and intraperitoneal injection of ferrostatin‐1 (Fer‐1) (2 mg/kg) was administered before anesthesia. On the third day after surgery, the cognitive ability of the aged mice was measured using the Y‐maze, and motor ability was assessed by total distance in the open field test. Transmission electron microscopy was used to observe hippocampal mitochondrial structure. Immunofluorescence staining was used to detect glutathione peroxidase 4 (GPX4) levels in the hippocampus. Flow cytometry measured ATP content and mitochondrial membrane potential in hippocampal mitochondria. A colorimetric assay was used to detect iron content in hippocampal neurons. Reverse transcription‐quantitative polymerase chain reaction and Western blotting were used to detect mRNA and protein expression of Solute carrier family 7 member (SLC7A11), transferrin receptor 1 (TFR1), iron regulatory protein 2 (IRP2), ferritin, SIRT1, nuclear factor erythroid 2‐related factor 2 (NRF2) and GPX4. The results showed that compared with the model group, the EA treatment group and the Fer‐1 (iron inhibitor) treatment group revealed improved ferroptosis and memory function in hippocampal neurons, while the EX527 (SIRT1 inhibitor) treatment group did not reveal any improvement. In conclusion, the occurrence and progression of PND are closely related to ferroptosis. EA stimulation of the Baihui and Dazhui acupoints can improve PND, possibly by regulating ferroptosis through the SIRT1/NRF2/GPX4 signalling pathway.

## Linked entities

- **Genes:** SIRT1 (sirtuin 1) [NCBI Gene 23411], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879], SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657], TFRC (transferrin receptor) [NCBI Gene 7037], IREB2 (iron responsive element binding protein 2) [NCBI Gene 3658]
- **Proteins:** SIRT1 (sirtuin 1), GABPA (GA binding protein transcription factor subunit alpha), GPX4 (glutathione peroxidase 4), SLC7A11 (solute carrier family 7 member 11), TFRC (transferrin receptor), IREB2 (iron responsive element binding protein 2), ferritin (soma ferritin-like)
- **Chemicals:** sevoflurane (PubChem CID 5206), EX527 (PubChem CID 707029), ferrostatin-1 (PubChem CID 4068248), Fer-1 (PubChem CID 4068248)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Mib2 (mindbomb E3 ubiquitin protein ligase 2) [NCBI Gene 76580] {aka 2210008I11Rik, Zzank1, skd}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, Mef2c (myocyte enhancer factor 2C) [NCBI Gene 17260] {aka 5430401D19Rik, 9930028G15Rik, Mef2}, Ireb2 (iron responsive element binding protein 2) [NCBI Gene 64602] {aka D9Ertd85e, Irp2}, Tert (telomerase reverse transcriptase) [NCBI Gene 21752] {aka EST2, TCS1, TP2, TR, TRT}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, Ache (acetylcholinesterase) [NCBI Gene 11423], Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Tfrc (transferrin receptor) [NCBI Gene 22042] {aka 2610028K12Rik, CD71, E430033M20Rik, Mtvr1, TFR, TFR1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Rbfox3 (RNA binding protein, fox-1 homolog (C. elegans) 3) [NCBI Gene 52897] {aka Fox-3, Hrnbp3, NeuN, Neuna60}, Aco1 (aconitase 1) [NCBI Gene 11428] {aka Aco-1, Irebp, Irp1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Slc7a11 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 11) [NCBI Gene 26570] {aka 9930009M05Rik, sut, xCT}
- **Diseases:** neuroinflammation (MESH:D000090862), cerebral hypoperfusion (MESH:D002547), neurodegenerative diseases (MESH:D019636), autoimmune diseases (MESH:D001327), Mitochondrial Dysfunction (MESH:D028361), atrophy (MESH:D001284), neurotoxicity (MESH:D020258), vascular dementia (MESH:D015140), cognitive decline (MESH:D003072), postoperative cognitive dysfunction (MESH:D000079690), postoperative pain (MESH:D010149), tibial fracture (MESH:D013978), Memory Deficits (MESH:D008569), postoperative complications (MESH:D011183), neurological disorders (MESH:D009461), fracture (MESH:D050723), inflammation (MESH:D007249), postoperative delirium (MESH:D000071257), decline (MESH:D060825), pain (MESH:D010146), Neurocognitive Disorder (MESH:D019965)
- **Chemicals:** glucose (MESH:D005947), JC-1 (MESH:C068624), glutaraldehyde (MESH:D005976), lipid (MESH:D008055), lidocaine (MESH:D008012), EX527 (MESH:C550547), Iron (MESH:D007501), GV 14 (-), ATP (MESH:D000255), ice (MESH:D007053), PVDF (MESH:C024865), Ferrozine (MESH:D005297), oxygen (MESH:D010100), ethanol (MESH:D000431), lipid peroxides (MESH:D008054), paraformaldehyde (MESH:C003043), water (MESH:D014867), alcohol (MESH:D000438), SYBR Green (MESH:C098022), Fer-1 (MESH:C573944), Sevoflurane (MESH:D000077149), NAD (MESH:D009243), paraffin (MESH:D010232)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12796855/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12796855/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12796855/full.md

---
Source: https://tomesphere.com/paper/PMC12796855